DEBTOR IN POSSESSION TERM LOAN AGREEMENT dated as of October 18, 2002Schedules and Exhibits • November 15th, 2002 • Eott Energy Partners Lp • Wholesale-petroleum bulk stations & terminals • New York
TABLE OF CONTENTSSchedules and Exhibits • May 19th, 1999 • Prism Financial Corp • Mortgage bankers & loan correspondents • Illinois
EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER BY AND BETWEEN HEATILATOR INC.Schedules and Exhibits • October 17th, 1996 • Hon Industries Inc • Office furniture (no wood) • Iowa
Exhibit 2.4 SCHEDULES AND EXHIBITS OMITTED FROM THE AGREEMENT AND PLAN OF MERGER AS FILED HEREWITH 1 Escrow Agreement 2 Registration Agreement 3 Paxton Employment Agreement 4 Paxton Option Agreement 5 Opinion of Counsel to ECI, Inc. 6 List of...Schedules and Exhibits • August 25th, 1999 • Cytation Com Inc • Services-computer programming services
AMENDED AND RESTATED AGREEMENT OF LIMITED PARTNERSHIP OF FOUR SPRINGS CAPITAL TRUST OPERATING PARTNERSHIP, L.P.Schedules and Exhibits • June 19th, 2017 • Four Springs Capital Trust • Real estate investment trusts • Delaware
Four Springs Capital Trust Operating Partnership, L.P. (the “Partnership”) was formed as a limited partnership under the laws of the State of Delaware, pursuant to a Certificate of Limited Partnership filed with the Secretary of State of the State of Delaware on July 10, 2012. An Agreement of Limited Partnership was entered into as of the 11th day of July, 2012 (the “Original Agreement”), by and among Four Springs Capital Trust, a Maryland trust (the “General Partner”), and the initial Limited Partners set forth on the signature pages of the Original Agreement.
COLLABORATION AND COMMERCIAL LICENSE AGREEMENT between MERSANA THERAPEUTICS, INC. and MERCK KGaASchedules and Exhibits • May 9th, 2023 • Mersana Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
This Collaboration and Commercial License Agreement, effective as of June 23, 2014 (“Effective Date”), is by and between Mersana Therapeutics, Inc., a Delaware corporation, having its principal place of business at 840 Memorial Drive Cambridge, MA 02139 (“Mersana”) and Merck KGaA, a corporation with general partners having its principal place of business at Frankfurter Str. 250, 64293 Darmstadt, Germany (“Merck”). Mersana and Merck may be referred to in this Agreement individually as a “Party” or collectively as the “Parties”.
OPTION PURCHASE AGREEMENTSchedules and Exhibits • February 23rd, 2004 • Medianews Group Inc • Newspapers: publishing or publishing & printing • New York
September 15, 2005 PIPER JAFFRAY & CO. U.S. Bancorp Center 800 Nicollet Mall Minneapolis, Minnesota 55402 Ladies and Gentlemen: Acacia Research Corporation, a Delaware corporation (the "COMPANY"), proposes, subject to the terms and conditions...Schedules and Exhibits • September 19th, 2005 • Acacia Research Corp • Electronic components & accessories • New York
Confidential Materials omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment under Rule 406 under the Securities Act of 1933, as amended. Confidential portions are marked: [ *** ]Schedules and Exhibits • June 19th, 2014 • Innocoll GmbH • Pharmaceutical preparations • Pennsylvania
This Amended and Restated Manufacture and Supply Agreement (this “Agreement”) is entered into as of April 27, 2010 (the “Restated MSA Effective Date”) by and among Innocoll Pharmaceuticals Limited, a corporation organized and existing under the laws of Ireland (“Innocoll Pharmaceuticals”), and Syntacoll AG, a company organized under the laws of Switzerland (“Syntacoll”) all located at c/o Innocoll Holdings, Inc. 42662 Kitchen Prim Ct., Ashburn, VA 20148 (Innocoll Pharmaceuticals and Syntacoll shall collectively be referred to herein as “Innocoll”),
